Impetigo herpetiformis with IL-36RN mutation successfully treated with secukinumab

Eur J Dermatol. 2018 Jun 1;28(3):381-382. doi: 10.1684/ejd.2018.3259.

Affiliations

¹ Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
² Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
³ Department of Dermatology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
⁴ Department of Dermatology, Fujita Health University School of Medicine, Aichi, Japan.

PMID: 30105995
DOI: 10.1684/ejd.2018.3259

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Dermatologic Agents / therapeutic use*
Female
Humans
Interleukins / genetics*
Mutation
Pregnancy
Pregnancy Complications / drug therapy*
Pregnancy Complications / genetics
Psoriasis / drug therapy*
Psoriasis / genetics

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Dermatologic Agents
IL36RN protein, human
Interleukins
secukinumab